# Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic Cancer

> **NCT00003591** · PHASE2 · COMPLETED · sponsor: **Radiation Therapy Oncology Group** · enrollment: 122 (actual)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **DRUG:** paclitaxel
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00003591
- **Lead sponsor:** Radiation Therapy Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-11
- **Primary completion:** 2001-06
- **Final completion:** 2005-10
- **Target enrollment:** 122 (ACTUAL)
- **Last updated:** 2013-11-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003591

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003591, "Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00003591. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*